Evidence map›Paper›PMID 28849134›Full record

ArticleMolecular medicine reports2017

[Corrigendum] Death receptor 5 expression is inversely correlated with prostate cancer progression.

Angeles Hernandez-Cueto, Daniel Hernandez-Cueto, Gabriela Antonio-Andres, Marisela Mendoza-Marin, Carlos Jimenez-Gutierrez, Ana Lilia Sandoval-Mejia, Rosario Mora-Campos, Cesar Gonzalez-Bonilla, Mario I Vega, Benjamin Bonavida and 1 more

Abstract readPublished Erratum
In one paragraph

Article in Molecular medicine reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Angeles Hernandez-CuetoImmunology and Infection Research Unit, National Medical Center 'La Raza', IMSS, Mexico City 02200, Mexico.
Daniel Hernandez-CuetoOncology Disease Research Unit, Children Hospital of Mexico 'Federico Gomez', Mexico City 06720, Mexico.
Gabriela Antonio-AndresOncology Disease Research Unit, Children Hospital of Mexico 'Federico Gomez', Mexico City 06720, Mexico.
Marisela Mendoza-MarinDepartment of Pathology, Hospital General Regional No. 25, IMSS, Mexico City 06720, Mexico.
Carlos Jimenez-GutierrezWomen Hospital, Mexico City 11340, Mexico.
Ana Lilia Sandoval-MejiaGineco‑Obstetricia Hospital No. 3, CMN 'La Raza', IMSS, Mexico City 02200, Mexico.
Rosario Mora-CamposSpeciality Hospital CMN 'La Raza', IMSS, Mexico City 02200, Mexico.
Cesar Gonzalez-BonillaImmunology and Infection Research Unit, National Medical Center 'La Raza', IMSS, Mexico City 02200, Mexico.
Mario I VegaOncology Research Unit, Oncology Hospital, Siglo XXI National Medical Center, IMSS, Mexico City 06720, Mexico.
Benjamin BonavidaDepartment of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
Sara Huerta-YepezOncology Disease Research Unit, Children Hospital of Mexico 'Federico Gomez', Mexico City 06720, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During the preparation of the figures in the above article, the authors inadvertently duplicated in Fig. 1B, a and b (high and low magnification images) the images that had already appeared as Figs. 5A, a and c (high and low magnification images), respectively, of the following paper: Huerta-Yepez S, Baritaki S, Baay-Guzman G, Hernandez-Luna MA, Hernandez-Cueto A, Vega MI and Bonavida B: Contribution of either YY1 or BclXL-induced inhibition by the NO-donor DETANONOate in the reversal of drug resistance, both in vitro and in vivo. Nitric Oxide 29: 17-24, 2013. The revised version of Fig. 1 containing the corrected data for Fig. 1B, a and b (high and low magnification images; the YY1 data) is shown opposite protein expression. All those authors whom the corresponding author was able to contact have agreed to this Corrigendum. The authors regret this error, and apologize for any confusion that it may have caused. [the original article was published in the Molecular Medicine Reports 10: 2279-2286, 2014; DOI: 10.3892/mmr.2014.2504 ].

Identifiers

PMID28849134
PMCPMC5647094

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.